Shareholders Unite are retired university professors from Amsterdam writing with a focus on small-cap, macro, value, and momentum. Our analysis can be read on TalkMarkets and Seeking Alpha.
Shareholders Unite are retired university professors from Amsterdam writing with a focus on small-cap, macro, value, and momentum. Our analysis can be read on TalkMarkets and Seeking Alpha.
less
Latest Comments
Protalix BioTherapeutics Well Placed To Advance In 2023
So they have a $96M market cap, rather than the $130M I assumed in the article and an EV of $76M, that's quite a bit less..
Protalix BioTherapeutics Well Placed To Advance In 2023
You're right, bit of a confusing sentence (the one quoted from the 10Q) but I read that the wrong way. First time I've seen that split out into 3 and 9 month periods, but they are almost entirely overlapping, not separate quantities I now realize.
SOBRSafe: A Very Favorable Risk/Reward Play
Well, signs of:
SOBRSafe: A Very Favorable Risk/Reward Play
It's now a $35M company, fully diluted with perhaps $20M in cash already after a lot of warrants converted recently. Just a little traction needed to turn this around, IMHO
A Paradigm Shift In Healthcare Produces A Big Market Opportunity
Thanks people, solid Q3 results
A Ground Floor Opportunity In Splash Beverage
Thanks Dick, appreciated
Bion Environmental Technologies Turns Waste Into Marketable Products
Thanks people, appreciated, it's interesting technology.
SurgePays Will Surge Ahead As Subscribers Flock To The Company
Thanks people. The recent investor talks like the one with JTC are also pretty interesting
Ituran Is Set To Recover
Yes, I was actually surprised how modestly priced the stock is, to be honest. Management is innovative and these applications tend to be quite sticky.
Ituran Is Set To Recover
My pleasure Dick, appreciated.